Creative Planning - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 124 filers reported holding NEWLINK GENETICS CORP in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q2 2018$106,000
-34.6%
22,2800.0%0.00%
-100.0%
Q1 2018$162,000
+6.6%
22,280
+18.6%
0.00%0.0%
Q4 2017$152,000
+145.2%
18,780
+124.1%
0.00%
Q2 2017$62,000
-41.5%
8,380
+91.3%
0.00%
-100.0%
Q1 2017$106,000
+135.6%
4,3800.0%0.00%
Q4 2016$45,000
-35.7%
4,380
-6.4%
0.00%
Q3 2016$70,000
+55.6%
4,680
+17.3%
0.00%
Q2 2016$45,000
-34.8%
3,991
+5.2%
0.00%
-100.0%
Q1 2016$69,000
-16.9%
3,792
+66.3%
0.00%0.0%
Q4 2015$83,0002,2800.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
FT Options LLC 21,900$1,292,0001.11%
TIVERTON ASSET MANAGEMENT LLC 288,807$18,215,0000.77%
Knoll Capital Management, LLC 102,437$1,153,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 460,146$5,181,0000.36%
WALL STREET ASSOCIATES 79,000$890,0000.36%
Endurant Capital Management LP 62,491$704,0000.24%
FT Options LLC 21,903$247,0000.21%
Virtus ETF Advisers LLC 24,463$275,0000.20%
Orbimed Advisors 1,581,506$17,808,0000.19%
HAP Trading, LLC 227,728$2,564,0000.15%
View complete list of NEWLINK GENETICS CORP shareholders